We are live on ! Find out more
ARMC

American Research & Management Company Portfolio holdings

AUM $362M
1-Year Est. Return 8.06%
This Fund
S&P 500
This Quarter Est. Return
+4.87%
1 Year Est. Return
-8.06%
3 Year Est. Return
+35.06%
5 Year Est. Return
+60.88%
10 Year Est. Return
AUM
$324M
AUM Growth
+$15.3M
Cap. Flow
+$2.42M
Cap. Flow %
0.75%
Top 10 Hldgs %
34.73%
Holding
385
New
33
Increased
82
Reduced
62
Closed
12

Sector Composition

Rank Sector Weight
1 Technology 23.71%
2 Miscellaneous 15.43%
3 Healthcare 14.57%
4 Consumer Staples 11.83%
5 Financials 10.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SCHB icon
101
Schwab US Broad Market ETF
SCHB
$44.7B
$307K 0.09%
28,512
+720
+3% +$7.55K
IBB icon
102
iShares Biotechnology ETF
IBB
$10.5B
$301K 0.09%
2,820
-165
-6% -$17.6K
FAST icon
103
Fastenal
FAST
$57.1B
$300K 0.09%
21,920
+1,160
+6% +$14.4K
TJX icon
104
TJX Companies
TJX
$149B
$299K 0.09%
7,814
+4,014
+106% +$146K
IWR icon
105
iShares Russell Mid-Cap ETF
IWR
$57.1B
$298K 0.09%
+5,724
New +$291K
SYBT icon
106
Stock Yards Bancorp
SYBT
$2.48B
$296K 0.09%
7,850
+3,100
+65% +$119K
PSF icon
107
Cohen & Steers Select Preferred & Income Fund
PSF
$234M
$287K 0.09%
10,165
+3,675
+57% +$104K
INTC icon
108
Intel
INTC
$473B
$285K 0.09%
6,177
+4,277
+225% +$187K
KHC icon
109
Kraft Heinz
KHC
$30.5B
$245K 0.08%
3,152
+1,337
+74% +$105K
ANCX
110
DELISTED
Access National Corp
ANCX
$241K 0.07%
8,649
+750
+9% +$21.5K
SYY icon
111
Sysco
SYY
$39.3B
$230K 0.07%
3,785
-200
-5% -$11.3K
JPM icon
112
JPMorgan Chase
JPM
$951B
$214K 0.07%
1,998
+171
+9% +$17.3K
CM icon
113
Canadian Imperial Bank of Commerce
CM
$104B
$207K 0.06%
4,244
TCF.PRC.CL
114
DELISTED
TCF Financial Corporation
TCF.PRC.CL
$206K 0.06%
8,000
BFAM icon
115
Bright Horizons
BFAM
$3.64B
$202K 0.06%
2,150
TCBIP
116
DELISTED
Texas Capital Bancshares, Inc. Non Cumulative Preferred Perpetual Stock Series A
TCBIP
$202K 0.06%
7,908
+5,906
+295% +$151K
AMLP icon
117
Alerian MLP ETF
AMLP
$13.4B
$195K 0.06%
3,615
+1,135
+46% +$60.7K
ABBV icon
118
AbbVie
ABBV
$451B
$193K 0.06%
1,997
+110
+6% +$10.4K
EXPD icon
119
Expeditors International
EXPD
$24.8B
$182K 0.06%
2,810
-300
-10% -$18.4K
AMZN icon
120
Amazon
AMZN
$2.87T
$177K 0.05%
3,020
+980
+48% +$53.9K
MMM icon
121
3M
MMM
$89.9B
$173K 0.05%
879
-239
-21% -$46K
CSCO icon
122
Cisco
CSCO
$433B
$169K 0.05%
4,400
+300
+7% +$10.7K
INDB icon
123
Independent Bank
INDB
$3.89B
$166K 0.05%
2,379
DIS icon
124
Walt Disney
DIS
$187B
$162K 0.05%
1,507
+970
+181% +$99.9K
SO icon
125
Southern Company
SO
$102B
$162K 0.05%
3,371
+640
+23% +$32.6K

Similar funds

American Research & Management Company's Q4 2017 Portfolio in Review

As of Q4 2017, American Research & Management Company held 385 positions worth $324M, up 5% from $309M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

American Research & Management Company's Q4 2017 filing shows 33 new, 82 increased, 62 reduced and 12 closed positions. Its largest new stake was iShares Russell Mid-Cap ETF: 5,724 shares worth $298K. The largest sale was IBM, an estimated $830K.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 24% a quarter earlier, followed by Miscellaneous and Healthcare.

  • American Research & Management Company's largest Q4 2017 buy was iShares Russell Mid-Cap ETF: 5,724 shares worth $298K.
  • American Research & Management Company added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $938K increase.
  • American Research & Management Company's biggest Q4 2017 reduction was IBM, cutting an estimated $830K.
  • American Research & Management Company fully exited Edwards Lifesciences in Q4 2017, selling an estimated $810K.
  • American Research & Management Company's ten largest holdings make up 35% of its $324M portfolio in Q4 2017.
  • American Research & Management Company opened 33 new positions and closed 12 in Q4 2017.
  • American Research & Management Company's portfolio value rose 5% quarter-over-quarter to $324M.

Based on American Research & Management Company's 13F filing for Q4 2017, filed 8 Feb 2018.